Oxygenta Pharmaceutical Faces Intense Selling Pressure Amid Consecutive Losses
Oxygenta Pharmaceutical Ltd is experiencing notable selling pressure, with the stock declining for eight consecutive days, resulting in a 13.8% drop. Despite a strong annual performance, the stock has struggled year-to-date. Current trading indicates it remains below several key moving averages, reflecting market sentiment challenges.
Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past eight days, resulting in a total decline of 13.8%. Today, Oxygenta's stock price fell by 1.99%, underperforming the Sensex, which decreased by only 0.32%.In terms of weekly performance, Oxygenta has dropped 9.58%, while the Sensex has seen a modest decline of 0.58%. Despite a strong performance over the past year, where Oxygenta gained 141.18% compared to the Sensex's 3.62%, the stock has struggled year-to-date, down 9.34% against the Sensex's decline of 3.12%.
The stock opened at 79.3 and has remained at this price level throughout the trading session. While Oxygenta's moving averages indicate it is above the 200-day average, it is currently below the 5-day, 20-day, 50-day, and 100-day moving averages. This trend may reflect underlying market sentiment and potential contributing factors to the ongoing selling pressure in the microcap pharmaceutical sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
